Her 2 in 1

Mark J Smyth; John Stagg

doi:10.1016/j.ccr.2010.07.009

Her 2 in 1

Cancer Cell. 2010 Aug 9;18(2):101-2. doi: 10.1016/j.ccr.2010.07.009.

Authors

Mark J Smyth¹, John Stagg

Affiliation

¹ Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Victoria, Australia. mark.smyth@petermac.org

PMID: 20708150
DOI: 10.1016/j.ccr.2010.07.009

Abstract

In this issue of Cancer Cell, Park et al. demonstrate that anti-erbB2 antibody primes adaptive immunity for increased tumor clearance and suggest that chemotherapy may in fact interfere with this process.

Publication types

Comment
Research Support, Non-U.S. Gov't